Quick Overview: In this episode of the Making Medicine Podcast, John Stanford breaks down the 2026 National Economic security is fast becoming one of the most important forces shaping global Michelle Ross, StemPoint Capital CIO, joins 'Closing Bell' to discuss Ross' thoughts on the recent news in the

Biotech Defense And Investment Trends - Detailed Overview & Context

In this episode of the Making Medicine Podcast, John Stanford breaks down the 2026 National Economic security is fast becoming one of the most important forces shaping global Michelle Ross, StemPoint Capital CIO, joins 'Closing Bell' to discuss Ross' thoughts on the recent news in the CNBC's “Closing Bell Overtime” team discusses why the Jared Holz, Mizuho, joins 'Power Lunch' to talk how to play healthcare and In this year-in-review episode, we break down key

As biology becomes a general-purpose technology shaping the economy and national security, sustaining US leadership in ... CHECK OUT MY FREE PRESENTATION ➡️ 101 Ways To Grow And Protect Your ... Explore Our SBIR/STTR Resources Consultation call: Access ... Jared Holz, Mizuho health care equity strategist, joins 'Power Lunch' to discuss Today's guest is Chris Clark. Chris was a Antoine Papiernik, managing partner at Sofinnova Partners, joins Yahoo Finance to discuss

In this episode, John Gagliano and Sheff Sheffield review the In this timely episode of BioTalk, returning guest Alex Philippidis, Senior Business Editor at Genetic Engineering & This is the first in a series of videos about how to

Photo Gallery

Biotech, Defense, and Investment Trends to Watch in 2026
Economic Security Watch: Why defence, biotech and national security are reshaping global investment
Confluence of factors are bringing investment into biotech sector, says StemPoint's Michelle Ross
This year's biotech laggards primed for 2026 recovery, says Goldman Sachs' Richter
Mizuho's Jared Holz on why he is bullish on biotech heading into 2026
Biotech in 2025: Investment Trends, Congress, and Approvals
Securing America’s Biotech Future | Policy Stories with Drew Endy
Why You Should Invest In Biotech Stocks
Biotech Stocks Are About to Explode in 2026 | 3 Picks Now
Biotech in focus: Is the sector poised for a comeback?
Top 3 Biotech Funding Trends: Where NIH, ARPA H, and DoD Are Investing in 2026
Single stock picking is the only way to make money in biotech, says Mizuho's Jared Holz
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored